| abstract |
The present invention relates to human antibodies that bind to human insulin-like growth factor-I receptor (IGF-IR), derivatives of these antibodies (Fabs, single chain antibodies, bispecific antibodies or fusion proteins), and therapeutics The use of antibodies and derivatives in methods and diagnostics. The present invention relates to nucleic acids encoding anti-IGF-IR, methods for producing and expressing antibodies. The invention further relates to combination therapy using an anti-IGF-IR antibody together with an anti-neoplastic agent. |